Psyched Wellness (PSYC) Ratios

5 Followers

Psyched Wellness Ratios

TSE:PSYC's free cash flow for Q4 2025 was C$0.42. For the 2025 fiscal year, TSE:PSYC's free cash flow was decreased by C$ and operating cash flow was C$-9.14. See a summary of the company’s cash flow.

Ratios	TTM	Feb 26	Feb 25	Feb 24	Feb 23
Liquidity Ratios
Current Ratio	―	5.78	17.39	23.93	16.11
Quick Ratio	―	4.51	15.72	20.76	14.76
Cash Ratio	―	3.49	14.15	20.19	12.96
Solvency Ratio	―	-7.80	-9.47	-11.29	-21.68
Operating Cash Flow Ratio	―	-6.29	-6.91	-9.99	-15.60
Short-Term Operating Cash Flow Coverage	―	0.00	0.00	0.00	0.00
Net Current Asset Value	C$ ―	C$ 3.09M	C$ 7.37M	C$ 6.96M	C$ 2.99M
Leverage Ratios
Debt-to-Assets Ratio	―	0.00	0.00	0.00	0.00
Debt-to-Equity Ratio	―	0.00	0.00	0.00	0.00
Debt-to-Capital Ratio	―	0.00	0.00	0.00	0.00
Long-Term Debt-to-Capital Ratio	―	0.00	0.00	0.00	0.00
Financial Leverage Ratio	―	1.21	1.06	1.04	1.06
Debt Service Coverage Ratio	―	0.00	0.00	0.00	-9.98
Interest Coverage Ratio	―	0.00	0.00	0.00	-9.48
Debt to Market Cap	―	0.00	0.00	0.00	0.00
Interest Debt Per Share	―	0.00	0.00	0.00	<0.01
Net Debt to EBITDA	―	0.44	1.41	1.84	0.60
Profitability Margins
Gross Profit Margin	―	40.18%	38.82%	48.49%	52.84%
EBIT Margin	―	-1076.95%	-725.50%	-1036.76%	-30093.91%
EBITDA Margin	―	-1075.81%	-724.70%	-1035.20%	-30084.53%
Operating Profit Margin	―	-1076.95%	-725.50%	-1036.76%	-28586.49%
Pretax Profit Margin	―	-1066.18%	-683.62%	-1069.15%	-30096.68%
Net Profit Margin	―	-1066.18%	-683.62%	-1069.15%	-30096.68%
Continuous Operations Profit Margin	―	-1066.18%	-683.62%	-1069.15%	-30096.68%
Net Income Per EBT	―	100.00%	100.00%	100.00%	100.00%
EBT Per EBIT	―	99.00%	94.23%	103.12%	105.28%
Return on Assets (ROA)	―	-134.29%	-54.02%	-46.78%	-129.76%
Return on Equity (ROE)	―	-162.18%	-57.28%	-48.80%	-138.01%
Return on Capital Employed (ROCE)	―	-163.82%	-60.79%	-47.32%	-131.09%
Return on Invested Capital (ROIC)	―	-163.82%	-60.79%	-47.32%	-131.09%
Return on Tangible Assets	―	-134.29%	-54.34%	-47.06%	-133.61%
Earnings Yield	―	-87.22%	-89.76%	-42.30%	-37.54%
Efficiency Ratios
Receivables Turnover	―	59.19	13.22	12.84	0.22
Payables Turnover	―	0.56	1.30	1.19	0.11
Inventory Turnover	―	0.34	0.51	0.17	0.03
Fixed Asset Turnover	―	24.26	25.06	10.61	0.59
Asset Turnover	―	0.13	0.08	0.04	<0.01
Working Capital Turnover Ratio	―	0.09	0.09	0.06	<0.01
Cash Conversion Cycle	―	417.07	467.96	1.85K	12.92K
Days of Sales Outstanding	―	6.17	27.60	28.42	1.64K
Days of Inventory Outstanding	―	1.06K	720.72	2.13K	14.46K
Days of Payables Outstanding	―	652.81	280.36	307.26	3.18K
Operating Cycle	―	1.07K	748.32	2.15K	16.10K
Cash Flow Ratios
Operating Cash Flow Per Share	―	-0.01	-0.01	-0.02	-0.02
Free Cash Flow Per Share	―	-0.01	-0.01	-0.02	-0.02
CapEx Per Share	―	0.00	<0.01	<0.01	<0.01
Free Cash Flow to Operating Cash Flow	―	1.00	1.00	1.02	1.03
Dividend Paid and CapEx Coverage Ratio	―	0.00	-1.12K	-40.81	-33.40
Capital Expenditure Coverage Ratio	―	0.00	-1.12K	-40.81	-33.40
Operating Cash Flow Coverage Ratio	―	0.00	0.00	0.00	0.00
Operating Cash Flow to Sales Ratio	―	-8.58	-4.98	-9.45	-216.46
Free Cash Flow Yield	―	-70.20%	-65.47%	-38.29%	-27.81%
Valuation Ratios
Price-to-Earnings (P/E) Ratio	―	-1.15	-1.11	-2.36	-2.66
Price-to-Sales (P/S) Ratio	―	12.22	7.62	25.28	801.71
Price-to-Book (P/B) Ratio	―	1.86	0.64	1.15	3.68
Price-to-Free Cash Flow (P/FCF) Ratio	―	-1.42	-1.53	-2.61	-3.60
Price-to-Operating Cash Flow Ratio	―	-1.42	-1.53	-2.68	-3.70
Price-to-Earnings Growth (PEG) Ratio	―	0.21	0.07	0.07	0.23
Price-to-Fair Value	―	1.86	0.64	1.15	3.68
Enterprise Value Multiple	―	-0.69	0.36	-0.60	-2.07
Enterprise Value	―	3.52M	-1.61M	1.99M	8.88M
EV to EBITDA	―	-0.69	0.36	-0.60	-2.07
EV to Sales	―	7.45	-2.59	6.19	621.83
EV to Free Cash Flow	―	-0.87	0.52	-0.64	-2.79
EV to Operating Cash Flow	―	-0.87	0.52	-0.66	-2.87
Tangible Book Value Per Share	―	0.01	0.03	0.04	0.02
Shareholders’ Equity Per Share	―	0.01	0.03	0.04	0.02
Tax and Other Ratios
Effective Tax Rate	―	0.00	0.00	0.00	0.00
Revenue Per Share	―	<0.01	<0.01	<0.01	<0.01
Net Income Per Share	―	-0.02	-0.02	-0.02	-0.03
Tax Burden	―	1.00	1.00	1.00	1.00
Interest Burden	―	0.99	0.94	1.03	1.00
Research & Development to Revenue	―	4.90	2.66	0.26	66.71
SG&A to Revenue	―	6.10	4.89	7.47	187.21
Stock-Based Compensation to Revenue	―	0.00	0.98	2.23	84.34
Income Quality	―	0.80	0.73	0.88	0.72

Currency in CAD